以 下是 贝壳 F Y25 Q1 的财报电话会纪要，财报点评请见《只要熬过楼市的 "过山车"，龙一贝壳就没毛病》 一、财报核心信息回顾 | BEKE (KE.US) earnings wrap | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2Q23 | Rmb mn | 1Q23 | | 3023 | 4Q23 | 1024 | 2024 | 3Q24 | 4Q24 | 1025 | 1Q25E | var | | 20,204 | Total revenue | 20,278 | 19,484 | 17,811 | | 16,377 | 23,370 | 22,585 | 31,125 | 23,328 | 22,487 | 3.7% | | 21% | yoy | 62% | 41% | 1% | | -19% | 20% | 27% | 54% | 42% | 37% | | | 6,050 | Existing home | 9,18 ...

因为和周四晚的阿里业绩撞车，海豚补上同日发布的贝壳业绩点评，整体来看当季增长表现好于预期，但上季开始的增收不增利的老问题并没解决。总营收大增 了 42%，但调整后净利润却同比增长 0%，具体要点如下： 1、 核心中核心的 存量房业务，本季 GTV 同比增加了 28% ， 政策红利的余温仍在 ，相比预期 24% 的增长，也是不错的 beat。根据贝壳研究院的调研，全国二手 房成交额同期内增长了 17%， 贝壳作为龙头，市占率仍在稳步提升，再度验证公司的统治地位。 由于 二手房的综合佣金率再度环比走低 （1.4bps） ，存量房业务的营收增长 20%，也跑输 GTV 的增速。 变现率走低主要原因是，GTV 结构中非自营业务占比上 升，也 可能有公司主动在佣金上让利促进成交的原因。 2、 由于去年基数极低 ，贝壳的新房业务增长看起来更强劲 ， 成交额同比增速高达 53%，环比进一步提速，远超市场预期的。 相较全国百强房企 1 季度操盘成 交额同比-6% 的增长，表明 新房业务上贝壳也有远超行业的表现，和获取优质房企和项目的出色能力 。 但类似二手房 ， 本季度 新房业务的综合变现率也是环比走低的 （下降 20bps ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36454 KIMBALL ELECTRONICS, INC. (Exact name of registrant as specified in its charter) incorporation or organization) Indiana 35 ...

Kimball Electronics (KE) Q3 2025 Earnings Call May 07, 2025 10:00 AM ET Company Participants Andrew Regrut - Treasurer & Investor Relations OfficerRichard Phillips - CEOJana Croom - Chief Financial OfficerMike Crawford - SMD & Head of Discovery GroupSteven Korn - COOJaeson Schmidt - Director of Research Conference Call Participants Derek Soderberg - Director, Senior Equity Research AnalystAnja Soderstrom - Senior Equity Research AnalystHendi Susanto - Research Analyst Operator Good morning, ladies and gentl ...

Kimball Electronics (KE) Q3 2025 Earnings Call May 07, 2025 10:00 AM ET Company Participants Andrew Regrut - Treasurer & Investor Relations OfficerRichard Phillips - CEOJana Croom - Chief Financial OfficerMike Crawford - SMD & Head of Discovery GroupSteven Korn - COOJaeson Schmidt - Director of Research Conference Call Participants Derek Soderberg - Director, Senior Equity Research AnalystAnja Soderstrom - Senior Equity Research AnalystHendi Susanto - Research Analyst Operator Good morning, ladies and gentl ...

Kimball Electronics (KE) Q3 2025 Earnings Call May 07, 2025 10:00 AM ET Speaker0 Good morning, ladies and gentlemen, and welcome to the Kimball Electronics Third Quarter Fiscal twenty twenty five Earnings Conference Call. My name is Kevin, and I'll be your facilitator for today's call. All lines have been placed in a listen only mode to prevent any background noise. After the completion of the prepared remarks from the Kimball Electronics leadership team, there will be a question and answer session. Today's ...

Quarter Ended March 31, 2025 Supplementary Information to the May 7, 2025, Earnings Conference Call & Webcast Lasting relationships. Global success. Kimball Electronics Third Quarter Fiscal 2025 Results Safe Harbor Statement Certain statements contained within this supplementary information, including our fiscal year 2025 guidance, and any statements made during our earnings conference call today may be considered forward-looking under the Private Securities Litigation Reform Act of 1995. The statements may ...

Kimball Electronics (KE) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.85%. A quarter ago, it was expected that this electronics manufacturing services company would post earnings of $0.24 per share when it actually produced earnings of $0.29, delivering a surprise of 20.83%.Over ...

Financial Performance - Net sales for Q3 fiscal 2025 totaled $374.6 million, a decrease of 12% compared to $425.0 million in Q3 fiscal 2024[4] - Operating income for Q3 was $11.7 million, representing 3.1% of net sales, with adjusted operating income at 4.2%[4] - Net sales for the three months ended March 31, 2025, were $374.6 million, a decrease of 11.8% compared to $425.0 million for the same period in 2024[19] - Gross profit margin decreased to 7.2% for the three months ended March 31, 2025, down from 7.9% in the prior year[19] - Operating income improved to $11.7 million for the three months ended March 31, 2025, compared to an operating loss of $6.4 million in the same period last year[19] - Net income for the three months ended March 31, 2025, was $3.8 million, a significant recovery from a net loss of $6.1 million in the prior year[19] - Net sales growth for the three months ended March 31, 2025, decreased by 12% compared to the same period in the prior year[25] - Adjusted operating income for the nine months ended March 31, 2025, was $41,629, down from $58,802 in the prior year[25] - Adjusted net income for the nine months ended March 31, 2025, was $19,718, compared to $31,607 in the prior year[25] - Operating income for the twelve months ended March 31, 2025, was $48,669, compared to $61,118 in the prior year[25] - Return on invested capital (ROIC) for the twelve months ended March 31, 2025, was 6.1%, down from 9.0% in the prior year[25] Cash Flow and Liquidity - Cash generated from operating activities was $30.9 million, marking the fifth consecutive quarter of positive cash flow[4] - Cash flow from operating activities for the nine months ended March 31, 2025, was $105.9 million, a substantial increase from $24.7 million in the same period of 2024[20] - The company has cash and cash equivalents of $51.4 million and available borrowing capacity of $253.2 million[4] - Borrowings on credit facilities decreased by $26.2 million from Q2, totaling $178.8 million, and down $116 million, or 40%, year-to-date[4] Inventory and Orders - Inventory decreased by $9.6 million from Q2 to $296.6 million[4] - The company reported a decrease in open orders to $642 million as of March 31, 2025, compared to $831 million a year earlier, primarily due to demand reductions[22][23] Expenses and Restructuring - Selling and administrative expenses for the three months ended March 31, 2025, were reported at $13,154, down from $16,861 in the prior year[25] - The company incurred restructuring expenses of $2.0 million for the three months ended March 31, 2025, compared to $1.6 million in the same period of 2024[19] - Restructuring expenses for the twelve months ended March 31, 2025, totaled $9,783, compared to $1,622 in the prior year[25] - Stock compensation expense for the nine months ended March 31, 2025, was $4,528, compared to $5,435 in the prior year[25] Future Outlook - The company expects fiscal 2025 net sales to be in the range of $1.40 billion to $1.44 billion, with adjusted operating income projected at 3.4% to 3.6% of net sales[9] - Capital expenditures for fiscal 2025 are estimated to be at the low-end of the guidance range of $40 million to $50 million[9] - A new manufacturing facility in Indianapolis is being added to support the company's strategy to drive growth in the medical CMO sector[4] Earnings Per Share - Basic earnings per share for the three months ended March 31, 2025, was $0.15, a recovery from a loss of $0.24 per share in the same period last year[19] - Diluted earnings per share, as reported, for the three months ended March 31, 2025, was $0.15, a decrease from $(0.24) in the prior year[25] - Adjusted diluted earnings per share for the nine months ended March 31, 2025, was $0.79, down from $1.25 in the prior year[25] - The current portion of long-term debt decreased to $28.9 million as of March 31, 2025, from $59.8 million in the previous year[21]

Safe Harbor Statement Certain statements contained within this supplementary information, including our fiscal year 2025 guidance, and any statements made during our earnings conference call today may be considered forward-looking under the Private Securities Litigation Reform Act of 1995. The statements may be identified by the use of words such as "expect," "should," "goal," "predict," "will," "future," "optimistic," "confident," and "believe." Undue reliance should not be placed on these forward- looking ...